A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma

Lung adenocarcinoma is one of the most malignant diseases worldwide. The immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) and programmed cell death-ligand 1 (PD-L1) have changed the paradigm of lung cancer treatment; however, there are still patients who are resistant. F...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Cell Dev Biol
Hlavní autoři: Zheng, Yujia, Tian, He, Zhou, Zheng, Xiao, Chu, Liu, Hengchang, Liu, Yu, Wang, Liyu, Fan, Tao, Zheng, Bo, Tan, Fengwei, Xue, Qi, Gao, Gengshu, Li, Chunxiang, He, Jie
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Cell and Developmental Biology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017122/
https://ncbi.nlm.nih.gov/pubmed/33816503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.651406
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky